Human Rhinovirus B14 Outbreak France 2024: Older Adults

French health officials have issued an urgent alert about a 2024 outbreak of Human Rhinovirus B14, a lesser-known rhinovirus variant causing severe respiratory illness and death primarily among older adults. Unlike typical rhinovirus infections that trigger mild colds, this strain is driving hospitalizations across multiple French regions, with long-term care facilities hit especially hard.

What Is Human Rhinovirus B14?

Rhinoviruses are the most common cause of the common cold, with hundreds of circulating variants. Human Rhinovirus B14 falls under the species B rhinovirus group, which accounts for roughly 20% of all rhinovirus infections globally.

Most B14 infections are mild, but the 2024 France outbreak marks one of the first times this variant has been linked to large-scale severe outcomes in high-risk populations. Early genetic sequencing shows this circulating strain has unique mutations not seen in previous B14 isolates.

2024 France Outbreak: Key Details

Santé Publique France, the country’s national public health agency, first detected unusual clusters of severe respiratory illness in January 2024. Cases were initially reported in long-term care facilities (LTCFs) in the Île-de-France region before spreading to 14 metropolitan regions.

Affected Populations

Over 85% of confirmed severe cases are adults aged 65 and older, with the median age of hospitalized patients being 78. Residents of LTCFs account for 60% of all reported cases, though community-dwelling older adults with underlying health conditions are also at high risk.

Reported Outcomes

As of March 2024, more than 180 confirmed Human Rhinovirus B14 cases have been linked to the outbreak, with 22 related deaths. Severe outcomes include viral pneumonia, acute respiratory distress syndrome (ARDS), and worsening of chronic conditions like COPD and congestive heart failure.

Why Is This Outbreak More Severe?

Three key factors are driving the unusually harsh impact of this Human Rhinovirus B14 outbreak in France:

• Age-related immune decline: Older adults have weaker innate and adaptive immune responses, making it harder to clear the virus before it reaches the lower respiratory tract.
• Variant mutations: The 2024 B14 strain has mutations in its VP1 capsid protein, which may increase its ability to bind to cells in the lungs rather than the upper respiratory tract.
• Co-infection risk: Many patients have tested positive for concurrent flu or COVID-19 infections, which worsen overall respiratory function.

Symptoms to Watch For

Early symptoms of this Human Rhinovirus B14 variant mimic a standard cold, but progress rapidly in high-risk groups. Watch for these red flags in older adults:

• Persistent dry or productive cough that worsens over 48 hours
• Shortness of breath, even when resting
• Fever above 38°C (100.4°F) lasting more than 3 days
• Extreme fatigue or confusion
• Worsening of pre-existing chronic respiratory or heart conditions

Prevention and Protection Tips

Older adults, caregivers, and LTCF staff can take these steps to reduce risk during the Human Rhinovirus B14 outbreak in France:

1. Stay up to date on all recommended respiratory vaccines, including flu, COVID-19, and pneumococcal shots. While no vaccine targets rhinovirus B14 directly, these shots reduce co-infection risk.
2. Practice strict hand hygiene: Wash hands with soap and water for 20 seconds, or use a 60%+ alcohol-based sanitizer when soap is unavailable.
3. Avoid close contact with people showing cold or flu-like symptoms. High-risk individuals should wear well-fitting masks in crowded indoor public spaces.
4. Improve indoor ventilation by opening windows for 10 minutes every hour, or using HEPA air purifiers in shared living spaces.
5. Seek immediate medical care if you or a loved one develops worsening breathing issues, confusion, or a fever that does not improve.

What Health Authorities Are Doing

Santé Publique France has ramped up nationwide surveillance for Human Rhinovirus B14, with free testing now available at all public health clinics for high-risk patients. LTCFs are required to report clusters of respiratory illness within 24 hours, and samples are being sequenced to track further mutations in the B14 strain.

Public awareness campaigns are also rolling out in multiple languages to reach older adults and caregivers across France, with targeted messaging for vulnerable communities.

While the 2024 Human Rhinovirus B14 outbreak in France is concerning, simple preventive steps can significantly reduce risk for older adults. Stay vigilant for symptoms, prioritize vaccination, and seek medical care early if respiratory issues develop. Health officials stress that most people will recover fully with prompt treatment, but high-risk groups need extra protection during this outbreak.